2021
DOI: 10.1101/2021.02.13.430988
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Synergistic application of continuous granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties

Abstract: This study demonstrated the first case of combining novel continuous granulation with powder-based pharmaceutical 3-dimensional (3D) printing processes to enhance the dissolution rate and physical properties of a poorly water-soluble drug. Powder bed fusion (PBF) and binder jetting 3D printing processes have gained much attention in pharmaceutical dosage form manufacturing in recent times. Although powder bed-based 3D printing platforms have been known to face printing and uniformity problems due to the inhere… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
1
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 57 publications
0
7
0
Order By: Relevance
“…Thereby, a 3D printing process utilizing a laser source meant to sinter is known as selective laser sintering (SLS) 5 . An SLS process like other powder-bed-based processes utilizes a hopper or a reservoir containing the feedstock (build material), which is dispensed onto the build platform utilizing a roller or a blade in a controlled fashion to maintain the required layer thickness set 6,7 . The fresh feedstock is spread over the build surface and the high-power laser either sinters or systematically melts the material (x, y, z) described by the underlying g-code 8 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thereby, a 3D printing process utilizing a laser source meant to sinter is known as selective laser sintering (SLS) 5 . An SLS process like other powder-bed-based processes utilizes a hopper or a reservoir containing the feedstock (build material), which is dispensed onto the build platform utilizing a roller or a blade in a controlled fashion to maintain the required layer thickness set 6,7 . The fresh feedstock is spread over the build surface and the high-power laser either sinters or systematically melts the material (x, y, z) described by the underlying g-code 8 .…”
Section: Introductionmentioning
confidence: 99%
“…Crucial processing parameters include laser speed, surface temperature, and chamber temperature, whereas print parameters include the layer height, number of perimeters, perimeter offset, hatching offset, and hatching spacing 13,14 . Moreover, material properties such as flowability impact the print quality and reproducibility for such powder-bed-based platforms, considering the precise layering and mass transfer required in the process 7,15,16 .…”
Section: Introductionmentioning
confidence: 99%
“…From previous studies without modifying the print bed, typically 150−200 g of feedstock is required based on the dimensions of the printlet, although the unsintered powder can be recycled. 7,14 The powder volume can be estimated based on the layer height of the print and the number of layers required to print the part. The second limitation is the absence of mixing of the powder blend during the process.…”
Section: Optimization Studiesmentioning
confidence: 99%
“…13,14 Moreover, material properties such as flowability impact the print quality and reproducibility for such powder-bed-based platforms, considering the precise layering and mass transfer required in the process. 7,15,16 Owing to the versatility of additive manufacturing processes for rapid prototyping (RP)/rapid tooling (RT), dosage form designing, and the porosity induced by such powder-bed processes, SLS has found application in the manufacturing of pharmaceutical dosage forms. 3 Previous studies depicting the use of SLS in dosage form development have revolved around immediate release dosage forms, 17 orally disintegrating tablets, 18 modified released dosage forms, and multidrug releasing systems.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation